The funds will expand Synpromics’ world leading R&D programmes in gene regulation for cell and gene medicines.

Daiichi Sankyo and Takeda Pharmaceuticals to leverage FDA-approved test for clinical trials and drug development programs.

Protein Metrics Inc., a leading provider of mass spectrometry software for protein characterization, has introduced the Byos™ platform, which automates biotherapeutic characterization workflows with just one click.

Comprehensive registration system offers new capabilities that enhance intellectual property protection and supports emerging methodologies in biologic drug discovery.

The Thermo Scientific Orion Star T900 Series is designed to automate QC/QA processes and boost efficiency.

High-resolution imaging and elemental analysis permit fast, accurate characterization of powdered raw materials and inspection of finished parts.

Oppilotech Ltd, a biopharmaceutical company founded to develop safe, first-in-class, antibacterial therapies, announced it has been selected for funding by Innovate UK – the UK’s innovation agency.

Stronger strategic investments for further sustainable growth.

New molecular strategy enriches multiple disease-related rare genetic DNA variants with high accuracy in a single assay to enable personalized diagnosis and treatments.

Porvair Sciences has collaborated with Persomics Inc. (Waltham, MA, USA) to develop and supply ANSI/SLAS format Arrays as an OEM product for their ImagineArray™ platform.